| 2025 | 2024 | |||
|---|---|---|---|---|
| Gross margin | -32,6 k € | +43.5% | -57,7 k € | |
| EBITDA | -32,6 k € | +43.4% | -57,7 k € | |
| Operating profit | -32,6 k € | +43.4% | -57,7 k € | |
| Profit/loss | -33,0 k € | +53.9% | -71,6 k € | |
| Equity | 210,3 k € | -13.6% | 243,4 k € | |
| Total assets | 212,9 k € | -13.6% | 246,4 k € | |
| Cash | 50,9 k € | -55.4% | 114,1 k € | |
| Debts | 2,5 k € | -16.6% | 3,0 k € | |
Source: Belgian Official Gazette
Private limited company · Waterloo · incorporated on 14/03/2024
Private limited company loss-making in the latest fiscal year. Cash position declining (-55.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Pharmazym is a Private limited company incorporated in 2024. Its registered office is in Waterloo.